Jacqualyn A. Fouse, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 21,444 shares at $21.64 ($464K) on 2024-01-24, disclosed to the SEC on 2024-01-24.
Scheduled sale ($464k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.64 | 10,722 | $232K | 50.0% |
| 2 | $21.64 | 10,722 | $232K | 50.0% |
| Total | $21.64 avg | 21,444 | $464K | 100% |
| Filing → |
| AGIO | SELL | 2024-01-09 | $386K | — | Filing → |
| AGIO | SELL | 2023-06-30 | $608K | — | Filing → |
| AGIO | BUY | 2019-11-15 | $1.2M | — | Filing → |